BioCentury
ARTICLE | Clinical News

Bridion sugammadex regulatory update

September 28, 2015 7:00 AM UTC

FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will meet on Nov. 6 to discuss an NDA from Merck for Bridion sugammadex to reverse neuromuscular blockade due to muscle relaxants rocuro...